




版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领
文档简介
1、HPLC-荧光检测器(HPLC-fluorescence detector),1,应用,Liquid chromatographic assay with fluorescence detection to determine ajmaline in serum from patients with suspected Brugada syndrome Rolf W. Sparidansa,Journal of Chromatography B,2010,2,Contents,3,ajmaline,A diagnostic agent to reveal the lectrocardiogra
2、phic characteristics in patients with suspected Brugada syndrome.,The Brugada syndrome is an electrical heart disease that affects predominantly adult males (male to female ratio 8:1) and has a high prevalence in South-East Asia.,Introduction,4,To evaluate the relationship between the pharmacokineti
3、cs and the observed ECG characteristics after intravenous administration of ajmaline, an assay for this drug in human serum samples was required.,GCMS after an extremely tedious sample pre-treatment using five liquidliquid extraction steps and derivatization.,a simple bioanalytical assay for ajmalin
4、e using LCfluorescence detection,5,Chemicals,Ajmaline(fluka) Acetonitrile(gradient grade) Methanol (HPLC grade) Perchloric acid(analytical grade) Home-purified water Human serum(pooled and from individual donors),6,equipment and conditions,Equipment :Shimadzu LC system Column:a Sentry Guard Symmetry
5、C18 pre-column (3.9mm20mm, 5m ) 、a Waters Symmetry C18 column(4.6mm100mm, 3.5m); 40 Mobile phase:pH 2.2perchloric acid-acetonitrile (77.5:22.5) flow rate 1.5 ml/min Detector :a FP-920 fluorescence detector excitation wavelength 290nm;memission 355nm ;,7,100l Serum,mixied vigorously by vortex mixing,
6、50l 10% (w/v) perchloric acid,centrifuged for 10 min at 0 and 12103g,Supernatant into an insert in an injection vial,15l into the LC system,Sample pre-treatment,8,perchloric acid,low pH (ca. 2.2) protonates the residual silanol groups,ion pairing properties increase the retention of the basic analyt
7、e.,comparison between trichloroacetic Acid and acetonitrile,Perchloric acid was chosen as a simple precipitating agents,9,one stock solution,pooled human serum,5278 ng/ml stored at 80 ,2111, 528, 211, 52.8 and 21.1 ng/ml prepared daily,blank matrix,ajmaline,methanol,ca. 1.2 mg/ml Stock solutions sto
8、red at 4 ,Calibration,calibration curves : the reversed square of the concentration of the analyte (1/x2) and the peak area of ajmaline.,10,Add Your Text,second stock solution,pooled human serum,QCsamples stored at 80 ,4160 (QC-high)、500 (QC-med)、50 (QC-low) 、25 (QC-LLQ) ng/ml,sextuple analysis of E
9、ach QC sample in three analytical runs on three separate days,Relative standard deviations within and between day precision,Precision and accuracy,11,Six individual serum samples,11 compounds,processed as blanks and after spiking with ajmaline at the LLQ level (25 ng/ml) and at 50 ng/ml,methadone, s
10、ulfamethoxazole, trimethoprim, ranitidine, caffeine, acetaminophen, oxazepam, rifampicin, pantoprazole, dexamethasone and metoclopramide,Blank serum samples,drug,near the upper therapeutic concentration,ajmaline at the LLQ level,Selectivity,12,Recovery,The extraction recovery was determined by compa
11、ring responses of processed samples (QC-high, -med and -low) with standard solutions at these levels in 25% (v/v) methanol,13,Stability,长期,冷冻-解冻循环3次,短期,Store 16h , 23 ,thawing at 23 during 12 h and freezing again at 80 for at least 1 day,8 months at 80 C,QC-high and low serum samples/Triplicate or q
12、uadruplicate analysis,溶液,storage 40 for 24 h and at 4 for 1 week,both stock solutions after 8 months storage at 4 ,QC-high, -med and -low serum samples,短期,处理后,14,Ten dosages to a second male subject (21 years of age, 90 kg body weight).,Nine aliquots of 2ml of 5 mg/ml to a male patient (77 years of
13、age, 90 kg body weight) with 1min intervals.,2,1,Patient samples,Blood samples were taken pre-dose and at approximately 1, 2, 5, 10, 15, 20, 30, 45, 60, 90, and 120 min after the last injection into glass tubes. After centrifugation at 3.5103g at ambient temperature for 5min, serum was separated and
14、 stored at 80 C until analysis with the presented assay,15,y = 1641(1263) + 758(34)x r= 0.9980.003 n=3 215300 ng/ml the lower limit of quantification was 25 ng/ml,16,Results and discussion,17,18,Selectivity,From the 11 drugs tested for potentially interference, sulfamethoxazole almost co- eluted wit
15、h ajmaline. All others did not interfere with the quantification of ajmaline.,extraction recoveries,QC-high57.70.1%, QC-med 56.11.4% QC-low 57.30.9% These relatively low recoveries showed excellent precisions and fulfilled the requirement of a bioanalytical assay,19,20,Pharmacokinetic curves of ajmaline in serum in two suspected Brugada syndrome patients during an ajmaline drug challenge test. (;) 21-year-old male; (; ) 77-year-old male.,21,A simple, accurate and precise bioanalytical assay for ajmaline has been pre
温馨提示
- 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
- 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
- 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
- 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
- 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
- 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
- 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。
最新文档
- 2025年中国EVA鞋材数据监测报告
- 2025年中国2.9-二甲基喹吖啶酮数据监测研究报告
- 2025至2030年中国龙韵石砖市场分析及竞争策略研究报告
- 2025至2030年中国陶瓷棺市场分析及竞争策略研究报告
- 2025至2030年中国铅合金产品市场分析及竞争策略研究报告
- 2025至2030年中国花泥树脂市场分析及竞争策略研究报告
- 2025至2030年中国线控工程车市场分析及竞争策略研究报告
- 2025至2030年中国矫形胸托市场分析及竞争策略研究报告
- 2025至2030年中国瓦楞针市场分析及竞争策略研究报告
- 2025至2030年中国滑片泵市场分析及竞争策略研究报告
- 棉印染清洁生产审核报告
- 板鞋竞速竞赛规则
- GB 6722-2014爆破安全规程
- 校企合作项目立项申请表(模板)
- 六旋翼无人机的设计(毕业设计)
- 假货鉴定报告
- 艺术概论:第八章综合艺术
- 云南省临沧市各县区乡镇行政村村庄村名居民村民委员会明细及行政区划代码
- 新人教版九年级物理全册知识点总结(课堂笔记)
- DB13T 5519.7-2022 轨道交通AFC系统线网技术要求 第7部分:数据接口
- 驻戈壁某部队糖尿病流行病学调查
评论
0/150
提交评论